William Maughan
Stock Analyst at Clear Street
(4.43)
# 1,112
Out of 4,345 analysts
140
Total ratings
48.1%
Success rate
15.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintained: Buy | $338 → $311 | $306.63 | +1.43% | 5 | May 4, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $32 → $31 | $17.36 | +78.57% | 6 | May 1, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $39 → $36 | $6.34 | +467.82% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Maintained: Buy | $17 | $5.39 | +215.40% | 2 | Mar 30, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $37 | $31.89 | +16.02% | 5 | Mar 25, 2026 | |
| CLLS Cellectis | Maintained: Buy | $9 | $3.63 | +147.93% | 2 | Mar 20, 2026 | |
| KRRO Korro Bio | Maintained: Buy | $18 | $13.76 | +30.81% | 5 | Mar 13, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | $6.6 | $2.31 | +186.33% | 10 | Mar 13, 2026 | |
| MOLN Molecular Partners AG | Maintained: Buy | $8 | $4.04 | +98.02% | 4 | Mar 13, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $181 → $167 | $93.00 | +79.57% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.6 | $3.57 | +28.85% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $130 | $86.67 | +49.99% | 2 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $6.69 | +572.65% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $2.31 | +462.77% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $28 | $8.54 | +227.87% | 6 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $27 | $10.91 | +147.48% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $50 | $53.53 | -6.59% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $67 | $28.54 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $12.91 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $9 | $2.37 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $11.72 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $3.19 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $106 | $47.61 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $4.57 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $26.87 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $196.97 | n/a | 1 | Sep 5, 2022 |
Krystal Biotech
May 4, 2026
Maintained: Buy
Price Target: $338 → $311
Current: $306.63
Upside: +1.43%
Summit Therapeutics
May 1, 2026
Maintained: Buy
Price Target: $32 → $31
Current: $17.36
Upside: +78.57%
Wave Life Sciences
Apr 28, 2026
Maintained: Buy
Price Target: $39 → $36
Current: $6.34
Upside: +467.82%
Annexon
Mar 30, 2026
Maintained: Buy
Price Target: $17
Current: $5.39
Upside: +215.40%
Beam Therapeutics
Mar 25, 2026
Maintained: Buy
Price Target: $37
Current: $31.89
Upside: +16.02%
Cellectis
Mar 20, 2026
Maintained: Buy
Price Target: $9
Current: $3.63
Upside: +147.93%
Korro Bio
Mar 13, 2026
Maintained: Buy
Price Target: $18
Current: $13.76
Upside: +30.81%
Century Therapeutics
Mar 13, 2026
Maintained: Buy
Price Target: $6.6
Current: $2.31
Upside: +186.33%
Molecular Partners AG
Mar 13, 2026
Maintained: Buy
Price Target: $8
Current: $4.04
Upside: +98.02%
BioNTech SE
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $93.00
Upside: +79.57%
Mar 10, 2026
Maintained: Buy
Price Target: $4.6
Current: $3.57
Upside: +28.85%
Mar 10, 2026
Reiterated: Buy
Price Target: $100 → $130
Current: $86.67
Upside: +49.99%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $6.69
Upside: +572.65%
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $2.31
Upside: +462.77%
Mar 2, 2026
Maintained: Buy
Price Target: $21 → $28
Current: $8.54
Upside: +227.87%
Feb 26, 2026
Maintained: Buy
Price Target: $29 → $27
Current: $10.91
Upside: +147.48%
Nov 11, 2025
Maintained: Hold
Price Target: $45 → $50
Current: $53.53
Upside: -6.59%
May 23, 2024
Maintained: Hold
Price Target: $67
Current: $28.54
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $24
Current: $12.91
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $11 → $9
Current: $2.37
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $38
Current: $11.72
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $16 → $15
Current: $3.19
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $91 → $106
Current: $47.61
Upside: n/a
Feb 20, 2024
Maintained: Buy
Price Target: $60
Current: $4.57
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $26.87
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $196.97
Upside: n/a